Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid
- 18 January 2009
- journal article
- Published by Elsevier BV in Pathology - Research and Practice
- Vol. 205 (5), 303-309
- https://doi.org/10.1016/j.prp.2008.11.011
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF‐D production by tumour cellsThe Journal of Pathology, 2007
- Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumorsLaboratory Investigation, 2005
- Follicular Neoplasms of the ThyroidAdvances in Anatomic Pathology, 2004
- Clinical Significance of Molecular Expression Profiles of Hürthle Cell Tumors of the Thyroid Gland Analyzed via Tissue MicroarraysThe American Journal of Pathology, 2002
- Strict Criteria Should Be Applied in the Diagnosis of Encapsulated Follicular Variant of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2002
- Gene expression in papillary thyroid carcinoma reveals highly consistent profilesProceedings of the National Academy of Sciences of the United States of America, 2001
- Guest Editorial: Two Proposals Regarding the Terminology of Thyroid TumorsInternational Journal of Surgical Pathology, 2000
- Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.The Journal of Experimental Medicine, 1989
- The Neural Cell Adhesion Molecule (NCAM) as a Regulator of Cell-Cell InteractionsScience, 1988
- Follicular variant of thyroid papillary carcinomaThe American Journal of Surgical Pathology, 1977